Agex Therapeutics Inc
Business Description
Agex Therapeutics Inc is a biotechnology company that focuses on the development of therapeutics to address age-related diseases. The company was founded in 2013 and is headquartered in Alameda, California.
Agex Therapeutics has a strong focus on the development of regenerative medicine and the use of small molecules to target aging-related pathways. Its mission is to extend the healthy human lifespan, and it aims to achieve this by developing innovative therapies that target the underlying processes of aging.
The company*s main area of expertise is the development of induced tissue regeneration (iTR) technology. This technology involves the use of cellular reprogramming to revert aged, dysfunctional cells back to a more youthful state. By doing so, Agex Therapeutics aims to restore normal tissue functioning and provide treatments for various age-related diseases and conditions.
Agex Therapeutics is particularly interested in conditions such as cardiovascular diseases, neurodegenerative disorders, and cancer, which are known to have a strong correlation with aging. By developing therapeutics that can reverse the aging process at the cellular level, the company aims to provide novel and effective treatments for these diseases.
The company also has a subsidiary called Lineage Cell Therapeutics, which focuses on the clinical development of iTR-based therapies. Lineage Cell Therapeutics is currently working on a number of clinical trials using iTR technology, including therapies for cardiac ischemia, Age-related Macular Degeneration (AMD), and dry eye disease.
Agex Therapeutics has a strong research and development team composed of experts in the fields of cell biology, molecular biology, and tissue engineering. The company actively collaborates with academic institutions, research organizations, and industry partners to advance its technologies and drug candidates.
In addition to its iTR technology, Agex Therapeutics is also engaged in the development and commercialization of other innovative aging-related therapies. The company is involved in the development of senolytics, which are drugs that selectively target senescent cells - cells that have stopped dividing and are associated with aging and age-related diseases. By eliminating senescent cells, Agex Therapeutics aims to promote tissue regeneration and restore proper cellular function.
The company*s research approach is data-driven, relying on genomics, proteomics, and other cutting-edge technologies to understand the underlying mechanisms of aging. This enables Agex Therapeutics to identify new targets for therapeutic intervention and develop novel drug candidates.
Overall, Agex Therapeutics is at the forefront of aging research and is dedicated to finding new and innovative therapies to address age-related diseases. With a focus on cellular reprogramming and tissue regeneration, the company aims to extend the healthy human lifespan and improve the quality of life for individuals affected by age-related conditions.
|